FAQs

CVS.

Click here for current stock quote.

Click here for price lookup.

Historical prices prior to March 22, 2007 reflect the price of CVS Corporation common stock only. Caremark stock was separately listed prior to that date.

New York Stock Exchange.

126650100

$0.01

Approximately 200,421 individuals own CVS Health common stock and approximately 2,666 institutions hold our stock representing 78.75% of shares outstanding.

No. Melville Corporation, a New York Corporation, was formerly a publicly traded company which operated a multitude of retail divisions, including CVS. In November 1996, following a merger with CVS Corporation, Melville shares became CVS Corporation shares. The merger agreement specifically stated the Melville shares do not have to be exchanged for CVS shares.

Your old Melville certificates are still valid and should be retained in a safe place.

CVS Health's transfer agent is EQ Shareowner Services. Click here for contact information.

Direct Registration is a service within the securities industry that allows shares to be owned and tracked electronically without having a stock certificate issued. Direct Registration means that instead of receiving a paper stock certificate to represent your CVS Health shares, your shares are held in your name and tracked electronically (in book-entry form) on CVS Health records, which are maintained by EQ Shareowner Services, transfer agent for CVS Health. For more information about Direct Registration, call EQ Shareowner Services toll-free at 1-877-CVS-PLAN.

Do not destroy any CVS stock certificates that you currently hold. These certificates remain valid for the number of shares shown.

If you hold shares that are not represented by a certificate, your new shares will be held in the same manner as those you currently hold.

You can purchase CVS Health stock and reinvest dividends without a broker through the EQ Shareowner Services’ "Shareowner Service Plus Plan^SM" program. Click here for information on the EQ Shareowner Services’ "Shareowner Service Plus Plan^SM" program.

CVS Health's dividend rate is currently $0.55 per share quarterly, which equates to an annual dividend rate of $2.20 per share.

Quarterly dividends are typically paid in February, May, August and November. Click here for dividend history.

Click here for dividend and stock split history.

CVS Corporation was incorporated in Delaware on August 22, 1996. It became a public company following a merger with Melville Corporation on November 20, 1996. On March 22, 2007, following its merger of equals with Caremark Rx, Inc., the Company’s name was changed to CVS Caremark Corporation. On September 3, 2014, the Company changed its name to CVS Health Corporation to better reflect its broader health care commitment as well as its understanding of the challenges faced by patients, payors, and providers.

Corporate headquarters are located in Woonsocket, RI.

As of December 31, 2021, the various subsidiaries of CVS Health employed approximately 300,000 people.

You can access our Annual Report through this website by clicking here. If you would like a hard copy of the Annual Report, please contact CVS Health’s Investor Relations department. Click here for contact information and here for an online information request form.

You can access our SEC filings through this website by clicking here. If you would like a hard copy of our reports on Form 10-K or 10-Q, please contact CVS Health’s Investor Relations department. Click here for contact information and here for an online information request form.

Stockholders and other parties interested in communicating directly with the non-management directors as a group may do so by writing to: Non-Management Directors, CVS Health Corporation, One CVS Drive, Woonsocket, RI 02895. The Nominating and Corporate Governance Committee has approved a process for handling letters received by the Company and addressed to non-management members of the Board. Under that process, the Corporate Secretary of the Company reviews all such correspondence and regularly forwards to the Board a summary of all such correspondence and copies of all correspondence that, in the opinion of the Corporate Secretary, deals with the functions of the Board or committees thereof or that he otherwise determines requires their attention. Directors shall from time to time review a log of all correspondence received by the Company that is addressed to members of the Board and may request copies of any such correspondence. Concerns relating to accounting, internal controls or auditing matters will be promptly brought to the attention of the Company’s internal audit department and handled in accordance with procedures established by the Audit Committee with respect to such matters.

CVS Health's last Annual Meeting was on May 11, 2022.

FAQs for former Aetna Shareholders available here.

The Aetna acquisition closed on November 28, 2018.

On November 28, 2018, Aetna Inc. (NYSE: AET) merged with an indirect subsidiary of CVS Health Corporation (NYSE: CVS). Aetna shareholders will receive $145.00 in cash and 0.8378 shares of CVS Health Corporation (NYSE: CVS) common stock, for every share of Aetna owned, with any fractional shares paid in cash.

For example, an owner of 100 shares of Aetna will receive $14,562 in cash and become the owner of 83 shares of CVS Health Corporation (100 shares of AET x 0.8378 = 83 shares of CVS Health and cash for the fractional .78 share).

Each holder of Aetna common stock will receive a letter of transmittal with instructions explaining how to exchange shares of Aetna common stock for shares of CVS Health common stock. For the cash portion of the consideration, payment will be deposited or made available within two days of the close of the transaction. For holders of certificates, the merger consideration will be paid only after surrender of your Aetna certificates as described in the letter of transmittal. If you cannot locate your Aetna stock certificates, the letter of transmittal will provide instructions on what to do.

In general, your exchange of shares of Aetna common stock for cash and shares of CVS Health is a taxable transaction for U.S. federal income tax purposes and may also be a taxable transaction under applicable state, local, or foreign income or other tax laws. You should consult your tax advisor about the tax consequences of exchanging your shares pursuant to the offer in light of your particular circumstances.

On August 18, 2015, CVS Health and its subsidiaries completed their acquisition of and Omnicare, Inc., previously announced on May 21, 2015. At the effective time of the acquisition, each share of Omnicare’s common stock, par value $1.00 per share, was converted into the right to receive $98.00 in cash, without interest and less any applicable withholding taxes.

No. If you held your shares of Omnicare common stock in certificated form, you were sent a letter of transmittal promptly after the completion of the merger, describing how you may exchange your shares of company common stock for the merger consideration. If you held your shares of company common stock in book-entry form, you were not sent a letter of transmittal with respect to your shares, unless you were otherwise required by the paying agent to deliver an executed letter of transmittal, in which case the paying agent sent you a letter of transmittal and appropriate instructions. If you were not required by the paying agent to deliver an executed letter of transmittal, you received payment for the merger consideration from the paying agent without any further action on your part. If your shares of company common stock were held in "street name" by your bank, brokerage firm or other nominee, you received instructions from your bank, brokerage firm or other nominee as to how to effect the surrender of your "street name" shares of company common stock in exchange for the merger consideration.

All shares of CVS stock are now automatically shares of CVS Health stock. CVS shares did not have to be exchanged for CVS Health shares.

Your old CVS certificates are still valid and should be retained in a safe place.

The Longs merger closed on October 30, 2008.

CVS Health paid $71.50 per share in cash, without interest, less any applicable withholding taxes but without brokerage fees or commissions or, except in certain circumstances, transfer taxes. If you were the record holder of your shares ( i.e. , a stock certificate has been issued to you) and you directly tendered your shares to us in the offer, you did not have to pay brokerage fees or similar expenses. If you owned your shares through a broker, banker or other nominee, and your broker tendered your shares on your behalf, your broker, banker or other nominee may have charged you a fee for doing so. You should consult your broker, banker or other nominee to determine whether any charges will apply.

We paid for your validly tendered and not withdrawn shares by depositing the purchase price with Mellon Investor Services LLC, which acted as your agent for the purpose of receiving payments from us and transmitting such payments to you. In all cases, payment for tendered shares of Longs common stock was made only after timely receipt by Mellon Investor Services LLC of certificates for such shares (or of a confirmation of a book-entry transfer of such shares), a properly completed and duly executed Letter of Transmittal (or facsimile thereof) and any other required documents for such shares.

Longs’ stockholders not tendering their shares in the offer received cash in an amount equal to the price per share paid in the offer. Therefore, the only difference between tendering and not tendering your shares was that tendering stockholders were paid earlier.

In general, your exchange of shares of Longs common stock for cash pursuant to the offer was a taxable transaction for U.S. federal income tax purposes and may also have been a taxable transaction under applicable state, local or foreign income or other tax laws. You should have consulted your tax advisor about the tax consequences to you of exchanging your shares pursuant to the offer in light of your particular circumstances.

To see Longs dividend history, click here.

The CVS Caremark merger closed March 22, 2007.

On March 22, 2007, Caremark Rx, Inc. (NYSE:CMX) merged with a subsidiary of CVS Corporation (NYSE:CVS). Caremark shareholders received 1.67 shares of CVS Corporation (NYSE:CVS), for every share of Caremark owned, with any fractional shares paid in cash. For example, an owner of 100 shares of Caremark became the owner of 167 shares of CVS Corporation (100 shares of CMX x 1.67 = 167 shares of CVS). The cost basis of your CVS stock is as follows:

CVS cost basis = (cost basis of Caremark) / 1.67

Caremark shareholders also received a special cash dividend of $7.50 for each share of Caremark owned. Using the above example, an owner of 100 shares of Caremark received $750 in addition to the 167 shares of CVS Corporation. Although the tax treatment of the Caremark special cash dividend is unclear, Caremark and CVS reported the special cash dividend as a qualified distribution with respect to Caremark common stock.

Each holder of Caremark common stock received a letter of transmittal for use in the exchange of Caremark common stock in the merger for CVS common stock and the payment of cash in lieu of fractional shares, and instructions explaining how to surrender stock certificates or transfer uncertificated shares of Caremark common stock. Holders of Caremark common stock that surrendered their stock certificates or transferred their uncertified shares together with a properly completed letter of transmittal, received the appropriate merger consideration.

Refer to pages 10 & 97 within the joint proxy statement filed on January 19, 2007, by clicking here.

American Stock Transfer & Trust Company is the paying agent for the special dividend. Click here for contact info.

On 11/30/92, Baxter spun off Caremark International. The spin-off was in the form of a special stock dividend. For every 4 shares of Baxter, you received 1 share of newly-created Caremark International. For example, if you owned 400 shares of Baxter, you would have received 100 shares of Caremark International. New cost basis were determined by multipliers that were based upon on the price of Baxter on 11/30/92. New cost basis are as follows:

Caremark International cost basis = (original cost basis* of Baxter) x .09177

*Note: Baxter split 2 for 1 on 11/17/83. If you purchased Baxter before this date, you must adjust your cost basis for the split. (original cost /2)

On 9/06/96, Caremark International merged with MedPartners. Caremark International shareholders received 1.21 shares of MedPartners for every share of Caremark International owned, with any fractional shares paid in cash. For example, an owner of 100 shares of Caremark International became the owner of 121 shares of MedPartners (100 shares x 1.21) = 121 shares of MDM. The cost basis of your MedPartners stock is as follows:

MedPartners cost basis = (cost basis of Caremark International) / 1.21

On September 13, 1999, MedPartners, Inc., changed its name to Caremark Rx, Inc., (NYSE: CMX) to reflect the Company's focus on its core pharmaceutical services operations. The name change did not affect shareholders or their MedPartners certificates.

Under the terms of the merger agreement, entered into on September 2, 2003, Caremark Rx acquired 100 percent of AdvancePCS's outstanding stock. AdvancePCS stockholders received value equivalent to 2.15 shares of Caremark Rx common stock for each AdvancePCS share, were paid 90% in Caremark Rx common stock and 10% in cash. For each share of AdvancePCS common stock held, AdvancePCS stockholders received:

• shares of Caremark Rx common stock in an amount equal to the product of (1) 2.15 and 0.90, or 1.935 shares of Caremark Rx common stock; and
• an amount in cash equal to 0.10 multiplied by the product of (1) 2.15 and (2) the average of the per share closing sales prices of shares of Caremark Rx common stock as reported on the NYSE during the five consecutive trading day period ending on, and including, the fifth trading day immediately prior to the effective time of the merger. Based on this pricing period, the resulting amount of cash received for each AdvancePCS share held was $7.01.

Stockholders of Caremark prior to the merger did not have to exchange their shares nor did they see any change in their account holdings as a result of the merger's completion. Stockholders of AdvancePCS were able to identify the conversion of their shares to Caremark shares through their account holdings statements if their shares are held by a bank or broker (in "street name"). Individual questions about Caremark or AdvancePCS stockholder accounts should be addressed through the Caremark stock transfer and exchange agent, Wachovia Bank at 1-800-829-8432.

Each stockholder should review the section of the Joint Proxy Statement entitled "Material U.S. Federal Income Tax Considerations" and consult his or her own tax advisor as to the tax consequences of the merger to such stockholder under Federal, state, local or other applicable law.

On a post two-for-one common stock split basis (June 1998 and June 2005), for each Arbor share exchanged in the merger, Arbor shareholders received 1.2728 shares of CVS common stock.

On a post two-for-one common stock split basis (June 1998 and June 2005), for each Revco share exchanged in the merger, Revco shareholders received 3.5368 shares of CVS common stock.

As owners of Melville common stock, you received a special distribution of .2879 shares of Footstar common stock for each share of Melville common stock owned as of the record date of October 2, 1996. For tax purposes these shares are treated as distributable on October 12, 1996. The income tax basis of your Melville common stock will have to be apportioned between your Melville common stock and the Footstar common stock based on their fair market values on the date of distribution - - October 12, 1996. (Because there was no trading on October 12th, the fair market value is determined with reference to the trading prices on October 11 and October 14, 1996). The fair market value of .2879 shares of Footstar common stock was $6.05 and the fair market value of one share of Melville common stock was $38.34. Your income tax basis in Melville common stock will be apportioned 13.6% to the Footstar common stock received and 86.4% to Melville common stock. The above is on a pre-stock split basis, we recommend that you consult your accountant for assistance.